Effect of Genetic Background on Manifestation of Progressive Fibrosing Interstitial Lung Diseases

被引：0
|
作者：
Sterclova, M.
Sikorova, K.
Kishore, A.
Petrek, M.
Vasakova, M.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7144
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prevalence of Progressive Fibrosing Interstitial Lung Disease
    Charest-Morin, Xavier
    Olson, Amy
    Wallace, Laura
    Hartmann, Nadine
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 823 - 823
  • [42] Nintedanib in patients with chronic fibrosing Interstitial lung diseases with progressive phenotype: the INBUILD trial
    Koschel, D.
    Flaherty, K. R.
    Wells, A. U.
    Cottin, V
    Devaraj, A.
    Inoue, Y.
    Richeldi, L.
    Walsh, S.
    Stowasser, S.
    Coeck, C.
    Goeldner, R. G.
    Clerisme-Beaty, E.
    Schlenker-Herceg, R.
    Brown, K. K.
    PNEUMOLOGIE, 2020, 74 : S106 - S107
  • [43] Effects of Nintedanib on Circulating Biomarkers in Subjects with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
    Maher, T. M.
    Jenkins, R. G.
    Bonella, F.
    Assassi, S.
    Diefenbach, C.
    Ittrich, C.
    Rohr, K. B.
    Kolb, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [44] Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases
    Holtze, Colin
    Flaherty, Kevin
    Kreuter, Michael
    Luppi, Fabrizio
    Moua, Teng
    Vancheri, Carlo
    Scholand, Mary B.
    EUROPEAN RESPIRATORY REVIEW, 2018, 27 (150):
  • [45] Efficacy and Safety of Nintedanib in Elderly Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
    Moua, T.
    Bonella, F.
    Okamoto, M.
    Tomassetti, S.
    Valenzuela, C.
    Wuyts, W.
    Miede, C.
    Lievens, D.
    Bendstrup, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [46] Present and future perspectives in early diagnosis and monitoring for progressive fibrosing interstitial lung diseases
    Stanel, Stefan Cristian
    Rivera-Ortega, Pilar
    FRONTIERS IN MEDICINE, 2023, 10
  • [47] Impact of weight loss on outcomes in patients with progressive fibrosing interstitial lung diseases (ILDs)
    Kreuter, M.
    Bendstrup, E.
    Maher, T. M.
    Inoue, Y.
    Miede, C.
    Lievens, D.
    Crestani, B.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [48] Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
    Hilberg, Ole
    Hoffmann-Vold, Anna-Maria
    Smith, Vanessa
    Bouros, Demosthenes
    Kilpelainen, Maritta
    Guiot, Julien
    Morais, Antonio
    Clemente, Susana
    Daniil, Zoe
    Papakosta, Despina
    Fretheim, Havard
    Neves, Sofia
    Alfaro, Tiago M.
    Antoniou, Katerina M.
    Valveny, Neus
    Asijee, Guus
    Soulard, Stephane
    Wuyts, Wim
    ERJ OPEN RESEARCH, 2022, 8 (01)
  • [49] Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers
    Faverio, Paola
    Piluso, Martina
    De Giacomi, Federica
    Della Zoppa, Matteo
    Cassandro, Roberto
    Harari, Sergio
    Luppi, Fabrizio
    Pesci, Alberto
    RESPIRATION, 2021, 99 (10) : 838 - 845
  • [50] Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
    Cottin, Vincent
    Hirani, Nikhil A.
    Hotchkin, David L.
    Nambiar, Anoop M.
    Ogura, Takashi
    Otaola, Maria
    Skowasch, Dirk
    Park, Jong Sun
    Poonyagariyagorn, Hataya K.
    Wuyts, Wim
    Wells, Athol U.
    EUROPEAN RESPIRATORY REVIEW, 2018, 27 (150):
12345